Opportunity Information: Apply for PA 13 138
Apply for PA 13 138
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Research on Marijuana Legalization in the US (Admin Supp)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 8, 2013 and posted on Mar 8, 2013.
- Applicants must submit their applications by May 31, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Research on Marijuana Legalization in the US (Admin Supp)" (Funding Opportunity Number PA-13-138) is an NIH National Institute on Drug Abuse (NIDA) administrative supplement announcement designed to add targeted, time-sensitive research aims onto existing NIH-funded projects. Rather than funding entirely new standalone studies, these administrative supplements are meant to help researchers who already hold an active parent award quickly incorporate analyses or data collection that can shed light on the real-world effects of changing marijuana laws and policies in the United States. The central purpose is to improve understanding of the social, behavioral, and public health impacts associated with recent moves toward marijuana legalization, including policy shifts at the state and local level.
A key focus of this opportunity is producing evidence that can inform policy and public health practice during a period of rapid legal and cultural change. NIDA’s intent is to support research that clarifies how legalization-related policies may influence patterns of marijuana use, perceptions of risk, initiation and cessation behaviors, availability and marketing, co-use with other substances, and downstream health and social outcomes. Because the announcement emphasizes social, behavioral, and public health impacts, relevant projects could include population-level analyses (for example, changes in prevalence, frequency, or modes of use), community and environmental impacts (such as retail density, enforcement practices, or exposure to advertising), and potential consequences for vulnerable groups. While the summary description is broad, the through-line is clear: generate rigorous, policy-relevant findings on how legalization laws and regulations intersect with substance use behaviors and public health indicators.
The announcement falls under the discretionary grant category and is associated with the Drug Abuse and Addiction Research Programs CFDA number 93.279. There is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of the award. NIDA estimated a total of $2,000,000 available under this initiative, with an award ceiling of $250,000 per supplement. In practice, that ceiling sets an upper bound on how much can be requested for the added work proposed under the administrative supplement, keeping projects focused and feasible within a shorter time horizon than a full new grant.
In terms of timing, the opportunity was posted and created on March 8, 2013, with an original and final closing date of May 31, 2013, and an archive date of July 1, 2013. Those dates indicate this was a limited-time initiative intended to capture an emerging policy moment and quickly build an evidence base while legalization policies were developing and expanding across states.
Eligibility is broad and includes many types of organizations typically able to hold NIH grants. Eligible applicants include nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding higher education institutions in that specific nonprofit category), public and private institutions of higher education, state and local governments (including county and city/township governments), special district governments, independent school districts, public housing authorities/Indian housing authorities, and tribal entities including federally recognized tribal governments and other tribal organizations. For-profit organizations other than small businesses are listed, and small businesses are also eligible, which together indicates that both commercial and non-commercial research organizations could potentially participate if they meet NIH requirements and hold an eligible parent award for an administrative supplement. The opportunity also explicitly notes additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. The overall message is that NIDA sought wide participation across academic, governmental, tribal, and community contexts, which is especially relevant for policy research where local conditions and implementation details can vary substantially.
The sponsoring agency is the National Institutes of Health, and the administering institute is NIDA. The official announcement link is provided through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-13-138.html. For access or technical issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, which is a standard point of contact for problems accessing or linking to the funding announcement materials.
In plain terms, this opportunity was meant to help existing NIH-funded research teams quickly pivot or extend their work so that they could evaluate the consequences of marijuana legalization as it unfolded. By offering administrative supplements with a defined ceiling and a short application window, NIDA positioned this as a way to rapidly generate credible findings that could guide decision-making around public health, prevention, regulation, and community impact during a major shift in U.S. drug policy.
Frequently Asked Questions (FAQs)
What is the "Research on Marijuana Legalization in the US (Admin Supp)" opportunity?
It is an NIH National Institute on Drug Abuse (NIDA) administrative supplement opportunity titled "Research on Marijuana Legalization in the US (Admin Supp)" under Funding Opportunity Number PA-13-138. The purpose is to add targeted, time-sensitive research aims to existing NIH-funded projects to study the real-world effects of changing marijuana laws and policies in the United States.
Is this funding for new, standalone research projects?
No. This is an administrative supplement announcement intended to support additions to active, NIH-funded parent awards. It is designed to help existing research teams quickly incorporate new analyses or data collection related to marijuana legalization, rather than launching entirely new independent studies.
What is the main goal of this administrative supplement?
The central goal is to improve understanding of the social, behavioral, and public health impacts associated with recent moves toward marijuana legalization, including policy shifts at the state and local level, during a period of rapid legal and cultural change.
What kinds of research topics does NIDA want to support under this opportunity?
The announcement emphasizes evidence that can inform policy and public health practice. Topics highlighted include how legalization-related policies may influence patterns of marijuana use, perceptions of risk, initiation and cessation behaviors, availability and marketing, co-use with other substances, and downstream health and social outcomes.
Does the opportunity focus on any particular type of impact?
Yes. The emphasis is on social, behavioral, and public health impacts of marijuana legalization laws and regulations, especially impacts that are policy-relevant and time-sensitive.
Are population-level studies within scope?
Yes. The description specifically notes population-level analyses, such as changes in prevalence, frequency, or modes of marijuana use.
Are community or environmental impacts within scope?
Yes. Examples mentioned include community and environmental impacts such as retail density, enforcement practices, and exposure to advertising.
Does the opportunity mention vulnerable groups?
Yes. It notes potential consequences for vulnerable groups as part of the broader set of social and public health outcomes that may be examined.
What is meant by "targeted, time-sensitive" research aims?
Within the context provided, it refers to add-on research activities that can be incorporated quickly into an existing NIH-funded project to address pressing questions while marijuana legalization policies are developing and expanding across states.
Which agency and institute sponsor and administer this opportunity?
The sponsoring agency is the National Institutes of Health (NIH), and the administering institute is the National Institute on Drug Abuse (NIDA).
What is the Funding Opportunity Number?
The Funding Opportunity Number is PA-13-138.
What is the CFDA number associated with this opportunity?
The opportunity is associated with the Drug Abuse and Addiction Research Programs CFDA number 93.279.
What is the grant category for this opportunity?
It is listed under the discretionary grant category.
Is there a cost sharing or matching requirement?
No. The opportunity states there is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award.
How much total funding did NIDA estimate for this initiative?
NIDA estimated a total of $2,000,000 available under this initiative.
What is the maximum amount that can be requested per supplement?
The award ceiling is $250,000 per supplement. This ceiling applies to the additional work proposed under the administrative supplement.
Why is there an award ceiling for the supplement?
Based on the information provided, the ceiling is intended to keep supplement projects focused and feasible, supporting added work within a shorter time horizon than a full new grant.
When was the opportunity posted and created?
It was posted and created on March 8, 2013.
What were the application closing dates?
The original and final closing date was May 31, 2013.
When was the opportunity archived?
The archive date was July 1, 2013.
What do the dates suggest about the intent of this initiative?
The limited-time posting and closing dates suggest it was designed to capture an emerging policy moment and quickly build an evidence base while marijuana legalization policies were developing and expanding across states.
Who is eligible to apply?
Eligibility is broad and includes many organization types typically able to hold NIH grants. Eligible applicants include nonprofit organizations (501(c)(3) and non-501(c)(3), excluding higher education institutions in that specific nonprofit category), public and private institutions of higher education, and multiple government entity types (state and local, county, and city/township governments).
Are tribal entities eligible?
Yes. Eligible applicants include federally recognized tribal governments and other tribal organizations.
Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also eligible.
Are special district governments and independent school districts eligible?
Yes. Special district governments and independent school districts are included in the eligible applicant list.
Are public housing authorities eligible?
Yes. Public housing authorities/Indian housing authorities are listed as eligible applicants.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are explicitly included among eligible applicant categories.
Does the opportunity encourage participation from specific institution types such as HBCUs or HSIs?
Yes. The opportunity explicitly notes additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations are included in the eligible applicant categories.
Are regional organizations and eligible federal agencies included as eligible applicants?
Yes. The eligibility list includes regional organizations and eligible federal agencies.
What is the official announcement link?
The official NIH Grants Guide announcement link is: http://grants.nih.gov/grants/guide/pa-files/PA-13-138.html
Who should be contacted for access or technical issues related to the announcement?
For access or technical issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
In plain terms, what was NIDA trying to accomplish with this supplement?
In plain terms, it was meant to help existing NIH-funded research teams quickly pivot or extend their work to evaluate the consequences of marijuana legalization as it unfolded, producing credible findings to guide decision-making around public health, prevention, regulation, and community impact.
Browse more opportunities from the same category: Education Health
Next opportunity: PsychENCODE Identification and Characterization of Non coding Functional Elements in the Brain, and their Role in the Development of Mental Disorders (R01)
Previous opportunity: Bioengineering Research Grants (BRG) (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 138
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 138) also looked into and applied for these:
| Funding Opportunity |
|---|
| Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 13 004 Funding Number: RFA OD 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Multicenter AIDS Cohort Study Center for the Coordination, Analysis, and Management of the MACS (CAMACS)(UM1) Apply for RFA AI 13 010 Funding Number: RFA AI 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,400,000 |
| Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) Apply for RFA AI 13 011 Funding Number: RFA AI 13 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $4,200,000 |
| Limited Competition Scholars Training for the Advancement of Research (STAR) Revision to NINR T32 Training Grants (T32) Apply for RFA NR 13 010 Funding Number: RFA NR 13 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 13 146 Funding Number: PAR 13 146 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 14 003 Funding Number: RFA DA 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 13 157 Funding Number: PA 13 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $175,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33) Apply for PAR 13 158 Funding Number: PAR 13 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 13 163 Funding Number: PAR 13 163 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R01) Apply for PA 13 165 Funding Number: PA 13 165 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R15) Apply for PA 13 166 Funding Number: PA 13 166 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R21) Apply for PA 13 167 Funding Number: PA 13 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 13 159 Funding Number: PAR 13 159 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Academic Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) Apply for PAR 13 169 Funding Number: PAR 13 169 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Dissertation Research (R36) Apply for PAR 13 182 Funding Number: PAR 13 182 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research in Integrative Cancer Biology (U01) Apply for PAR 13 184 Funding Number: PAR 13 184 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Image guided Drug Delivery in Cancer (R01) Apply for PAR 13 185 Funding Number: PAR 13 185 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R01) Apply for RFA MH 14 170 Funding Number: RFA MH 14 170 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Eradication of HIV 1 from CNS Reservoirs Implications for Therapeutics (R21) Apply for RFA MH 14 171 Funding Number: RFA MH 14 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Detection of Pathogen Induced Cancer (DPIC) (R01) Apply for PAR 13 190 Funding Number: PAR 13 190 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 138", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.